ranolazine has been researched along with Obesity in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eaton, F; Gopal, K; Greenwell, AA; Saed, CT; Tabatabaei Dakhili, SA; Ussher, JR | 1 |
| Al Batran, R; Chan, JSF; Eaton, F; Gopal, K; Greenwell, AA; Saed, CT; Tabatabaei Dakhili, SA; Ussher, JR; Yang, K | 1 |
| Fischer, KL; Heitner, SB | 1 |
| Battaglia, D; Caminiti, G; Fossati, C; Massaro, R; Rosano, G; Volterrani, M | 1 |
1 review(s) available for ranolazine and Obesity
| Article | Year |
|---|---|
Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Diet, Healthy; Disopyramide; Exercise Therapy; Health Status; Healthy Lifestyle; Humans; Obesity; Ranolazine; Risk Reduction Behavior; Sleep Apnea Syndromes | 2019 |
4 other study(ies) available for ranolazine and Obesity
| Article | Year |
|---|---|
The anti-anginal ranolazine does not confer beneficial actions against hepatic steatosis in male mice subjected to high-fat diet and streptozotocin-induced type 2 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diet, High-Fat; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Ranolazine; Streptozocin; Triglycerides | 2022 |
The antianginal ranolazine fails to improve glycaemia in obese liver-specific pyruvate dehydrogenase deficient male mice.
Topics: Animals; Diet, High-Fat; Glucose; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Oxidoreductases; Ranolazine | 2023 |
Ranolazine improves insulin resistance in non-diabetic patients with coronary heart disease. A pilot study.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Agents; Coronary Disease; Diabetes Mellitus, Type 2; Exercise Test; Female; Follow-Up Studies; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Pilot Projects; Ranolazine | 2016 |
New drugs for prevention, relief. How you might benefit if 3 medications win FDA approval.
Topics: Acetanilides; Angina Pectoris; Benzazepines; Heart Failure; Humans; Obesity; Piperazines; Piperidines; Pyrazoles; Ranolazine; Rimonabant; Tolvaptan | 2005 |